Efficacy of Next Line of Therapy After Treatment with Lenvatinib (Len) in Combination with Pembrolizumab (Pembro) Versus Treatment of Physician’s Choice (Tpc) in Patients (Pts) with Advanced Endometrial Cancer (Aec): Exploratory Analysis of Study 309/Keynote-775.